Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma.
Journal
Sarcoma
ISSN: 1357-714X
Titre abrégé: Sarcoma
Pays: Egypt
ID NLM: 9709257
Informations de publication
Date de publication:
2021
2021
Historique:
received:
19
05
2020
revised:
17
08
2020
accepted:
07
01
2021
entrez:
19
2
2021
pubmed:
20
2
2021
medline:
20
2
2021
Statut:
epublish
Résumé
Six cell surface receptors, human epidermal growth factor receptor-2 (Her-2), platelet-derived growth factor receptor- Patient-derived OS cell lines ( All 6 receptors were variably expressed in the majority of cell lines. IR and PDGFR- The six cell surface receptors demonstrated variable expression across the majority of patient-derived OS cell lines tested. Limited prognostic value was offered by IR and PDGFR-
Sections du résumé
BACKGROUND
BACKGROUND
Six cell surface receptors, human epidermal growth factor receptor-2 (Her-2), platelet-derived growth factor receptor-
METHODS
METHODS
Patient-derived OS cell lines (
RESULTS
RESULTS
All 6 receptors were variably expressed in the majority of cell lines. IR and PDGFR-
CONCLUSION
CONCLUSIONS
The six cell surface receptors demonstrated variable expression across the majority of patient-derived OS cell lines tested. Limited prognostic value was offered by IR and PDGFR-
Identifiants
pubmed: 33603563
doi: 10.1155/2021/8324348
pmc: PMC7872755
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8324348Subventions
Organisme : NCI NIH HHS
ID : U10 CA180886
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA180899
Pays : United States
Informations de copyright
Copyright © 2021 Yoav Zvi et al.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Cancer. 2008 May 15;112(10):2119-29
pubmed: 18338812
Cancer Sci. 2015 Jul;106(7):875-82
pubmed: 25940371
Pediatr Blood Cancer. 2016 Oct;63(10):1761-70
pubmed: 27362300
Mol Med Rep. 2018 Dec;18(6):5221-5228
pubmed: 30280196
Ann Oncol. 2015 Feb;26(2):407-14
pubmed: 25421877
Am J Transl Res. 2016 Aug 15;8(8):3439-47
pubmed: 27648134
Technol Cancer Res Treat. 2016 Oct;15(5):NP40-8
pubmed: 26306402
Curr Probl Cancer. 2019 Jun;43(3):228-235
pubmed: 30217668
Cancer. 2012 Jul 15;118(14):3455-67
pubmed: 22086782
J Clin Oncol. 2005 Dec 1;23(34):8845-52
pubmed: 16246977
Medicine (Baltimore). 2016 Jun;95(23):e3661
pubmed: 27281068
Int J Cancer. 2017 Oct 1;141(7):1469-1477
pubmed: 28631382
Mod Pathol. 2000 Jun;13(6):632-7
pubmed: 10874667
J Surg Oncol. 2012 Mar;105(3):235-43
pubmed: 21866554
Pathol Res Pract. 2017 Aug;213(8):895-899
pubmed: 28647210
Mol Med Rep. 2019 Apr;19(4):3345-3352
pubmed: 30816452
Cell Physiol Biochem. 2016;38(2):598-608
pubmed: 26845446
Lancet Oncol. 2020 Mar;21(3):446-455
pubmed: 32078813
Cancer Gene Ther. 2012 Mar;19(3):212-7
pubmed: 22173710
Med Sci Monit. 2017 Aug 27;23:4132-4140
pubmed: 28844074
Cancer. 2012 Feb 1;118(3):740-9
pubmed: 21751203
Am J Surg Pathol. 2001 Dec;25(12):1520-7
pubmed: 11717542
Cancer. 2009 Apr 1;115(7):1531-43
pubmed: 19197972
Pediatr Blood Cancer. 2008 Feb;50(2):254-8
pubmed: 17262795
J Clin Oncol. 2005 Mar 20;23(9):2004-11
pubmed: 15774791
Cancer Treat Rev. 2010 Jun;36(4):277-85
pubmed: 20231056
Pediatr Blood Cancer. 2010 Jul 15;55(1):67-75
pubmed: 20486173
BMC Cancer. 2013 May 20;13:245
pubmed: 23688189
Nucl Med Biol. 2016 Dec;43(12):812-817
pubmed: 27744117
Nat Rev Cancer. 2012 Feb 16;12(3):159-69
pubmed: 22337149
Cancer Biomark. 2018;23(3):315-322
pubmed: 30223385
Lancet Oncol. 2015 Jan;16(1):98-107
pubmed: 25498219
Oncogene. 2003 Apr 17;22(15):2334-42
pubmed: 12700668
Pathol Oncol Res. 2020 Jul;26(3):1787-1795
pubmed: 31676993
FEBS J. 2018 Apr;285(7):1359-1371
pubmed: 29474747
Ann Transl Med. 2017 Jan;5(1):5
pubmed: 28164090
Eur J Cancer. 2019 Mar;109:36-50
pubmed: 30685685
Clin Exp Med. 2016 Nov;16(4):577-584
pubmed: 26319790
Oncol Rep. 2014 Jan;31(1):328-34
pubmed: 24172910
J Clin Oncol. 2012 Jul 10;30(20):2545-51
pubmed: 22665540
Cancer. 2002 Mar 1;94(5):1397-404
pubmed: 11920494
J Cell Mol Med. 2019 May;23(5):3293-3301
pubmed: 30773847
Sci Rep. 2019 Aug 7;9(1):11476
pubmed: 31391495
Int J Cancer. 2009 Jul 1;125(1):229-34
pubmed: 19330840
Pediatr Blood Cancer. 2014 Sep;61(9):1558-64
pubmed: 24753182
Mol Cancer Ther. 2010 Oct;9(10):2652-64
pubmed: 20924128
Med Sci Monit. 2019 Aug 19;25:6236-6243
pubmed: 31425497
Cancer Res. 2009 Mar 15;69(6):2443-52
pubmed: 19258511
Sci Rep. 2018 Mar 8;8(1):4177
pubmed: 29520051